Y. Vered et al., BIOAVAILABILITY OF LEVODOPA AFTER CONSUMPTION OF VICIA-FABA SEEDLINGSBY PARKINSONIAN-PATIENTS AND CONTROL SUBJECTS, Clinical neuropharmacology, 17(2), 1994, pp. 138-146
Recently, we have shown that ingestion of Vicia faba beans improved su
bstantially the clinical features in parkinsonian patients. However, t
he supply of the beans is season-dependent and their digestion can be
quite unpleasant due to flatulence. In the present study, we verified
that the L-Dopa content of V. faba seedlings is 20-fold higher than th
at of the fruit. Moreover, the germination of the seedlings is easy an
d not season-dependent, and their ingestion does not cause any adverse
digestive effects. In the present study, seven Parkinson's disease (P
D) patients and nine healthy controls ingested V. faba seedlings. Plas
ma L-Dopa and dihydroxyphenylacetic acid (DOPAC) levels were measured
by a high performance liquid chromatography with electrochemical detec
tion (HPLC-ECD) method. Plasma L-Dopa increased in both populations, a
nd a substantial clinical improvement was observed in the patients acc
ording to the Webster scale. Vicia faba seedling ingestion is a useful
tool in the treatment of PD patients, especially those in low-income
societies where limited resources do not allow the purchase or manufac
ture of expensive drugs. This treatment might also appeal to those peo
ple who prefer natural treatment in PD and in other conditions for whi
ch L-Dopa is prescribed.